These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22174138)

  • 1. Stargazing from a new vantage--TARP modulation of AMPA receptor pharmacology.
    Jackson AC; Nicoll RA
    J Physiol; 2011 Dec; 589(Pt 24):5909-10. PubMed ID: 22174138
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmembrane AMPA receptor regulatory protein regulation of competitive antagonism: a problem of interpretation.
    Maclean DM; Bowie D
    J Physiol; 2011 Nov; 589(Pt 22):5383-90. PubMed ID: 21969453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stargazin modulates AMPA receptor antagonism.
    Cokić B; Stein V
    Neuropharmacology; 2008 Jun; 54(7):1062-70. PubMed ID: 18378265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local infusion of the (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione does not block D1 dopamine receptor-mediated increases in immediate early gene expression in the dopamine-depleted striatum.
    Keefe KA; Gerfen CR
    Neuroscience; 1999 Mar; 89(2):491-504. PubMed ID: 10077330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamatergic modulation of subcortical motor and limbic circuits.
    Healy DJ; Meador-Woodruff JH
    Ann N Y Acad Sci; 1999 Jun; 877():684-7. PubMed ID: 10415683
    [No Abstract]   [Full Text] [Related]  

  • 6. The non-NMDA glutamate receptor antagonists 6-cyano-7-nitroquinoxaline-2,3-dione and 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline, but not NMDA antagonists, block the intrastriatal neurotoxic effect of MPP+.
    Merino M; Vizuete ML; Cano J; Machado A
    J Neurochem; 1999 Aug; 73(2):750-7. PubMed ID: 10428073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of AMPA receptor gating and pharmacology by TARP auxiliary subunits.
    Milstein AD; Nicoll RA
    Trends Pharmacol Sci; 2008 Jul; 29(7):333-9. PubMed ID: 18514334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late embryonic expression of AMPA receptor function in the CA1 region of the intact hippocampus in vitro.
    Diabira D; Hennou S; Chevassus-Au-Louis N; Ben-Ari Y; Gozlan H
    Eur J Neurosci; 1999 Nov; 11(11):4015-23. PubMed ID: 10583490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection.
    Radenovic L; Selakovic V
    Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNQX increases GABA-mediated synaptic transmission in the cerebellum by an AMPA/kainate receptor-independent mechanism.
    Brickley SG; Farrant M; Swanson GT; Cull-Candy SG
    Neuropharmacology; 2001 Nov; 41(6):730-6. PubMed ID: 11640927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
    Mead AN; Stephens DN
    J Pharmacol Exp Ther; 1999 Jul; 290(1):9-15. PubMed ID: 10381753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of AMPA-type glutamate receptor antagonists on intermale social behavior in two mouse lines bidirectionally selected for offensive aggression.
    Vekovischeva OY; Aitta-aho T; Verbitskaya E; Sandnabba K; Korpi ER
    Pharmacol Biochem Behav; 2007; 87(2):241-9. PubMed ID: 17537494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonists.
    Maj J; Rogóz Z; Skuza G; Jaros T
    Pol J Pharmacol; 1995; 47(4):269-77. PubMed ID: 8616504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPA- and kainate-receptors differentially mediate excitatory amino acid-induced dopamine and acetylcholine release from rat striatal slices.
    Jin S
    Neuropharmacology; 1997; 36(11-12):1503-10. PubMed ID: 9517420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NMDA and AMPA receptor antagonists on corticosterone facilitation of long-term memory in the chick.
    Venero C; Sandi C
    Eur J Neurosci; 1997 Sep; 9(9):1923-8. PubMed ID: 9383215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPA and NMDA receptors mediate synaptic excitation in the rat's inferior colliculus.
    Ma CL; Kelly JB; Wu SH
    Hear Res; 2002 Jun; 168(1-2):25-34. PubMed ID: 12117506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar AMPA/KA receptor antagonism by CNQX inhibits vestibuloocular reflex adaptation.
    Carter TL; McElligott JG
    Exp Brain Res; 2005 Oct; 166(2):157-69. PubMed ID: 16082536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early activation of Ca(2+)-permeable AMPA receptors reduces neurite outgrowth in embryonic chick retinal neurons.
    Catsicas M; Allcorn S; Mobbs P
    J Neurobiol; 2001 Nov; 49(3):200-11. PubMed ID: 11745658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of GYKI 52466 and CNQX, AMPA/kainate receptor antagonists, on the micturition reflex in the rat.
    Yoshiyama M; Roppolo JR; de Groat WC
    Brain Res; 1995 Sep; 691(1-2):185-94. PubMed ID: 8590052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new pathway for lactate production in the CNS.
    Kasischke KA
    J Physiol; 2008 Mar; 586(5):1207-8. PubMed ID: 18310130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.